Cumberland Pharmaceuticals Shares Jump After $100M Sale of Branded Medicines to Apotex
Cumberland Pharmaceuticals said it will sell its branded pharmaceuticals business to an affiliate of Apotex for $100 million in cash, a move that lifted its stock approximately 80% on the announcement. The Nashville-based company will retain its clinical pipeline, majority ownership of Cumberland Emerging Technologies Inc., and plans to prioritize …